我国28个省市区医药制造业技术创新能力评价

Evaluation of Technological Innovation Capability of Pharmaceutical Enterprises in 28 Provinces, Cities and Regions in China

目的:评价我国28个省市区医药制造业的技术创新能力,为各省市区制订相关决策提供依据。方法:总结现有的关于我国医药制造业技术创新能力评价的文献,构建医药制造业技术创新评价指标体系,采用因子分析法对28个省市区的医药制造业的相关数据进行分析,得出综合评分及排名,并提出相关建议。结果:设定创新能力投入、创新能力产出、创新能力支持3个一级指标构建医药制造业技术创新评价指标体系,并以这3个指标为公共因子。江苏、山东和浙江排名前三,其技术创新能力的综合评分分别为2.1197、1.8265、0.9107;甘肃、山西和宁夏排名最后,其技术创新能力的综合评分分别为-0.4660、-0.4672、-0.4784。结论:对于创新能力较高(技术创新能力综合评分皆≥-0.1195)的12个省市区来说,在保持创新优势的基础上,要进一步提高技术创新能力,力求和国际接轨;对于技术创新能力较低(技术创新能力综合评分皆<-0.1195)的16个省市区来说,要充分认识到本省医药制造业技术创新的不足之处,制订相关决策,提高技术创新能力。

OBJECTIVE： To evaluate technological innovation capability of pharmaceutical enterprises in 28 provinces, cities and regions and provide basis for making interrelated decision. METHODS： Literatures about technological innovation capability of pharmaceutical enterprises in China were summarized. Evaluation index system of technological innovation capability for pharmaceutical enterprises had been established. Factor analysis was used to analyze the data of pharmaceutical enterprises in 28 provinces, cities and districts. Comprehensive score and sorting were obtained, and relevant suggestions were put forward. RESULTS： Evaluation index system of technological innovation capability had been established, including innovation capability input, innovation capability output and innovation capability support as common factors. Jiangsu, Shandong and Zhejiang ranked the top three, and their innovation capability score were 2.119 7, 1.826 5 and 0.910 7; Gansu, Shanxi and Ningxia ranked the last three, and their innovation capability score were - 0.466 0, - 0.467 2 and - 0.478 4. CONCLUSIONS： For those 12 provinces, cities and districts whose score are above -0.1 19 5, technological innovation capability should be further improved on the basis of preserving innovation advantage to follow international community; for those 16 provinces, cities and districts whose score are below -0.119 5, the deficiency of technological innovation should be fully realized to make related decision for increasing innovation capability.